OptimizeRx Corporation (OPRX)
USD 7.32
(-5.61%)
USD 7.32
(-5.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -21.3 Million USD | -21.03% |
| 2022 | -9.41 Million USD | -519.55% |
| 2021 | 2.32 Million USD | 2923.2% |
| 2020 | -59.43 Thousand USD | 104.56% |
| 2019 | -2.75 Million USD | -457.56% |
| 2018 | 1.23 Million USD | 127.51% |
| 2017 | -1.8 Million USD | -43.98% |
| 2016 | -1.3 Million USD | -380.08% |
| 2015 | -261.19 Thousand USD | 27.66% |
| 2014 | -761.05 Thousand USD | -188.1% |
| 2013 | 409.81 Thousand USD | 331.83% |
| 2012 | -267.34 Thousand USD | 86.48% |
| 2011 | -1.01 Million USD | 24.18% |
| 2010 | -1.78 Million USD | 33.28% |
| 2009 | -4.52 Million USD | -75.71% |
| 2008 | -4.21 Million USD | -316.52% |
| 2007 | -353.11 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -3.96 Million USD | 57.52% |
| 2024 Q2 | -2.67 Million USD | 36.71% |
| 2023 FY | - USD | -21.03% |
| 2023 Q3 | -3.08 Million USD | 30.12% |
| 2023 Q4 | -7.2 Million USD | -133.42% |
| 2023 Q1 | -6.59 Million USD | -1518.25% |
| 2023 Q2 | -4.41 Million USD | 33.07% |
| 2022 Q1 | -3.28 Million USD | -391.79% |
| 2022 Q4 | -407.8 Thousand USD | 87.42% |
| 2022 FY | - USD | -519.55% |
| 2022 Q2 | -3.33 Million USD | -1.24% |
| 2022 Q3 | -3.24 Million USD | 2.69% |
| 2021 Q1 | -112.12 Thousand USD | -106.0% |
| 2021 FY | - USD | 2923.2% |
| 2021 Q2 | 868.09 Thousand USD | 874.2% |
| 2021 Q3 | 564.22 Thousand USD | -35.0% |
| 2021 Q4 | 1.12 Million USD | 99.81% |
| 2020 Q1 | -1.68 Million USD | -50.17% |
| 2020 FY | - USD | 104.56% |
| 2020 Q3 | 457.08 Thousand USD | 190.51% |
| 2020 Q2 | -505.01 Thousand USD | 70.02% |
| 2020 Q4 | 1.86 Million USD | 308.78% |
| 2019 Q3 | -1.3 Million USD | -258.09% |
| 2019 FY | - USD | -457.56% |
| 2019 Q1 | 344.83 Thousand USD | 1147.67% |
| 2019 Q4 | -1.12 Million USD | 13.75% |
| 2019 Q2 | 822.61 Thousand USD | 138.56% |
| 2018 Q4 | 27.63 Thousand USD | -90.77% |
| 2018 FY | - USD | 127.51% |
| 2018 Q3 | 299.4 Thousand USD | 6.73% |
| 2018 Q2 | 280.5 Thousand USD | 308.24% |
| 2018 Q1 | -134.7 Thousand USD | -5.51% |
| 2017 Q3 | -490.31 Thousand USD | -114.08% |
| 2017 Q4 | -127.67 Thousand USD | 73.96% |
| 2017 Q1 | -798.2 Thousand USD | -109.18% |
| 2017 Q2 | -229.02 Thousand USD | 71.31% |
| 2017 FY | - USD | -43.98% |
| 2016 Q1 | -351.75 Thousand USD | -9.33% |
| 2016 Q3 | -189.94 Thousand USD | 50.13% |
| 2016 Q2 | -380.87 Thousand USD | -8.28% |
| 2016 Q4 | -381.59 Thousand USD | -100.9% |
| 2016 FY | - USD | -380.08% |
| 2015 Q2 | -77.86 Thousand USD | -144.63% |
| 2015 Q4 | -321.73 Thousand USD | -288.99% |
| 2015 Q3 | 170.23 Thousand USD | 318.65% |
| 2015 FY | - USD | 27.66% |
| 2015 Q1 | -31.82 Thousand USD | 86.88% |
| 2014 Q3 | -328.04 Thousand USD | -8264.29% |
| 2014 Q4 | -242.51 Thousand USD | 26.07% |
| 2014 FY | - USD | -188.1% |
| 2014 Q1 | 205.48 Thousand USD | 3892.33% |
| 2014 Q2 | 4018.00 USD | -98.04% |
| 2013 FY | - USD | 331.83% |
| 2013 Q1 | -56.77 Thousand USD | -134.2% |
| 2013 Q4 | 5147.00 USD | -91.28% |
| 2013 Q2 | 402.34 Thousand USD | 808.72% |
| 2013 Q3 | 59 Thousand USD | -85.34% |
| 2012 Q2 | -28.73 Thousand USD | 88.72% |
| 2012 Q1 | -254.71 Thousand USD | 65.54% |
| 2012 FY | - USD | 86.48% |
| 2012 Q4 | 166.01 Thousand USD | 379.77% |
| 2012 Q3 | -59.33 Thousand USD | -106.54% |
| 2011 Q3 | -260.78 Thousand USD | 0.67% |
| 2011 Q1 | -45.45 Thousand USD | 72.89% |
| 2011 Q2 | -262.53 Thousand USD | -477.58% |
| 2011 Q4 | -739.1 Thousand USD | -183.41% |
| 2011 FY | - USD | 24.18% |
| 2010 Q1 | -252.77 Thousand USD | 28.34% |
| 2010 Q3 | -496.41 Thousand USD | 42.72% |
| 2010 FY | - USD | 33.28% |
| 2010 Q2 | -866.6 Thousand USD | -242.84% |
| 2010 Q4 | -167.65 Thousand USD | 66.23% |
| 2009 Q4 | -352.75 Thousand USD | 32.04% |
| 2009 FY | - USD | -75.71% |
| 2009 Q3 | -519.02 Thousand USD | -50.79% |
| 2009 Q2 | -344.19 Thousand USD | 74.85% |
| 2009 Q1 | -1.36 Million USD | -8.46% |
| 2008 Q1 | 125.26 Thousand USD | 0.0% |
| 2008 Q3 | -152.13 Thousand USD | -207.64% |
| 2008 Q2 | 141.34 Thousand USD | 12.84% |
| 2008 FY | - USD | -316.52% |
| 2008 Q4 | -1.26 Million USD | -729.28% |
| 2007 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 31.9% |
| Augmedix, Inc. | -17.68 Million USD | -20.516% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 106.097% |
| CareCloud, Inc. | -31.29 Million USD | 31.9% |
| HealthEquity, Inc. | 282.41 Million USD | 107.545% |
| iCoreConnect Inc. | -11.87 Million USD | -79.373% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 111.422% |
| Nutex Health, Inc. | -14.58 Million USD | -46.135% |
| Omnicell, Inc. | 60.69 Million USD | 135.11% |
| OneMedNet Corporation | -11.97 Million USD | -78.004% |
| Progyny, Inc. | 64.46 Million USD | 133.054% |
| Renalytix Plc | -28.52 Million USD | 25.289% |
| Schrödinger, Inc. | -171.89 Million USD | 87.604% |
| Simulations Plus, Inc. | 6.13 Million USD | 447.552% |
| SOPHiA GENETICS SA | -70.7 Million USD | 69.861% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | -66.264% |
| Ontrak, Inc. | -14.41 Million USD | -47.811% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 100.599% |
| Sharecare, Inc. | -67.25 Million USD | 68.317% |
| Aclarion, Inc. | -4.14 Million USD | -414.644% |
| CareMax, Inc. | -590.46 Million USD | 96.391% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | -303.946% |
| Forian Inc. | 2.75 Million USD | 874.769% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | -303.946% |
| HeartBeam, Inc. | 675 Thousand USD | 3256.8% |
| GeneDx Holdings Corp. | -136.46 Million USD | 84.385% |
| SCWorx Corp. | -3.97 Million USD | -436.101% |
| Minerva Surgical, Inc. | -20.07 Million USD | -6.155% |
| Definitive Healthcare Corp. | -241.22 Million USD | 91.167% |
| 10x Genomics, Inc. | -205.11 Million USD | 89.611% |
| Zhongchao Inc. | -4.9 Million USD | -334.657% |
| Accolade, Inc. | -71.19 Million USD | 70.07% |
| MSP Recovery, Inc. | -69.22 Million USD | 69.217% |
| R1 RCM Inc. | 426.2 Million USD | 105.0% |
| Spok Holdings, Inc. | 26.29 Million USD | 181.03% |
| Privia Health Group, Inc. | 27.18 Million USD | 178.392% |
| EUDA Health Holdings Limited | -8.3 Million USD | -156.717% |
| TruBridge, Inc. | -15.39 Million USD | -38.447% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 106.097% |
| Sharecare, Inc. | -67.25 Million USD | 68.317% |
| Health Catalyst, Inc. | -66.46 Million USD | 67.939% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 119.581% |
| Premier, Inc. | 286.08 Million USD | 107.448% |
| HealthStream, Inc. | 59.58 Million USD | 135.76% |
| Certara, Inc. | 23.84 Million USD | 189.366% |
| GeneDx Holdings Corp. | -136.46 Million USD | 84.385% |
| Ontrak, Inc. | -14.41 Million USD | -47.811% |
| SHL Telemedicine Ltd. | 3.28 Million USD | 748.951% |
| CareCloud, Inc. | -31.29 Million USD | 31.9% |
| EUDA Health Holdings Limited | -8.3 Million USD | -156.717% |
| HeartBeam, Inc. | 675 Thousand USD | 3256.8% |
| Mangoceuticals, Inc. | -9.18 Million USD | -131.927% |
| CareMax, Inc. | -590.46 Million USD | 96.391% |
| Healthcare Triangle, Inc. | -4.1 Million USD | -419.21% |
| National Research Corporation | 45.98 Million USD | 146.338% |
| Aclarion, Inc. | -4.14 Million USD | -414.644% |